Clinical Trials
38 trialsRemoval of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Institutes of Health Clinical Center (CC)
Vaccine Therapy in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
National Institutes of Health Clinical Center (CC)
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
National Institutes of Health Clinical Center (CC)
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
National Institutes of Health Clinical Center (CC)
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
National Institutes of Health Clinical Center (CC)
Continuation of Follow-up of DES-Exposed Cohorts
National Institutes of Health Clinical Center (CC)
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Studying Normal Breast Tissue and Cancer Risk
National Institutes of Health Clinical Center (CC)
Breast Tissue Study of Breast Diseases Among Women in Hong Kong
National Institutes of Health Clinical Center (CC)
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
National Institutes of Health Clinical Center (CC)
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)
National Institutes of Health Clinical Center (CC)
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
National Institutes of Health Clinical Center (CC)
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
National Institutes of Health Clinical Center (CC)
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
AT13387 in Adults With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Prospective Study of Health in Runners and Walkers
National Heart, Lung, and Blood Institute (NHLBI)
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
National Cancer Institute (NCI)
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
National Cancer Institute (NCI)
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
National Cancer Institute (NCI)
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Role of Gene Variation in Effectiveness of Gleevec Treatment
National Institutes of Health Clinical Center (CC)
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
National Institutes of Health Clinical Center (CC)
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
National Institutes of Health Clinical Center (CC)
Vinorelbine and XR9576 to Treat Cancer
National Institutes of Health Clinical Center (CC)
Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts
National Institutes of Health Clinical Center (CC)